Annex 1 and sterilization process: an interview with Tim Sandle
Overall impact of new Annex 1 in pharmaceutical industry
The revision of Annex 1 is requiring a major effort from the life sciences industry; from ‘setting up new processes, to training staff, to managing noncompliance, the industry needs to adapt particularly to new requirements regarding contamination control strategy and the essential elements needed…